Page 71 - Read Online

Novati et al. Ageing Neur Dis 2022;2:17 https://dx.doi.org/10.20517/and.2022.19 Page 25 of 29

176. Schulz GM, Grant MK. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson’s
disease. J Commun Disord 2000;33:59-88. DOI PubMed
177. Kwan LC, Whitehill TL. Perception of speech by individuals with Parkinson’s disease: a review. Parkinsons Dis 2011;2011:389767.
DOI PubMed PMC
178. Smotherman MS. Sensory feedback control of mammalian vocalizations. Behav Brain Res 2007;182:315-26. DOI PubMed PMC
179. Depaulis A, Keay KA, Bandler R. Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray
region of the rat. Exp Brain Res 1992;90:307-18. DOI PubMed
180. Fardin V, Oliveras J, Besson J. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in
the rat. I. The production of behavioral side effects together with analgesia. Brain Research 1984;306:105-23. DOI PubMed
181. Schulz GM, Varga M, Jeffires K, Ludlow CL, Braun AR. Functional neuroanatomy of human vocalization: an H215O PET study.
Cereb Cortex 2005;15:1835-47. DOI PubMed
182. Van Daele DJ, Cassell MD. Multiple forebrain systems converge on motor neurons innervating the thyroarytenoid muscle.
Neuroscience 2009;162:501-24. DOI PubMed PMC
183. Jürgens U. The role of the periaqueductal grey in vocal behaviour. Behavioural Brain Research 1994;62:107-17. DOI PubMed
184. Beart P, Summers R, Stephenson J, Christie M. Excitatory amino acid projections to the nucleus of the solitary tract in the rat: a
retrograde transport study utilizing d-[3H]aspartate and [3H]GABA. J Auton Nerv Syst 1994;50:109-22. DOI PubMed
185. Bennett PJG, Maier E, Brecht M. Involvement of rat posterior prelimbic and cingulate area 2 in vocalization control. Eur J Neurosci
2019;50:3164-80. DOI PubMed PMC
186. Oka T, Tsumori T, Yokota S, Yasui Y. Neuroanatomical and neurochemical organization of projections from the central amygdaloid
nucleus to the nucleus retroambiguus via the periaqueductal gray in the rat. Neurosci Res 2008;62:286-98. DOI PubMed
187. Grant LM, Richter F, Miller JE, et al. Vocalization deficits in mice over-expressing α-synuclein, a model of pre-manifest Parkinson’s
disease. Behav Neurosci 2014;128:110-21. DOI PubMed PMC
188. Kelm-Nelson CA, Gammie S. Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset
parkinsonism in Pink1 knockout rats. BMC Genomics 2020;21:625. DOI PubMed PMC
189. Johnson RA, Kelm-Nelson CA, Ciucci MR. Changes to ventilation, vocalization, and thermal nociception in the Pink1-/- rat model of
Parkinson’s disease. J Parkinsons Dis 2020;10:489-504. DOI PubMed PMC
190. Kelm-Nelson CA, Brauer AFL, Barth KJ, et al. Characterization of early-onset motor deficits in the Pink1-/- mouse model of
Parkinson disease. Brain Res 2018;1680:1-12. DOI PubMed PMC
191. Kummer A, Cardoso F, Teixeira AL. Loss of libido in Parkinson’s disease. J Sex Med 2009;6:1024-31. DOI PubMed
192. Murphy AZ, Hoffman GE. Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem
pathway: a potential circuit for the initiation of male sexual behavior. J Comp Neurol 2001;438:191-212. DOI PubMed
193. Normandin JJ, Murphy AZ. Nucleus paragigantocellularis afferents in male and female rats: organization, gonadal steroid receptor
expression, and activation during sexual behavior. J Comp Neurol 2008;508:771-94. DOI PubMed PMC
194. Cullen KP, Grant LM, Kelm-Nelson CA, et al. Pink1-/- rats show early-onset swallowing deficits and correlative brainstem
pathology. Dysphagia 2018;33:749-58. DOI PubMed PMC
195. van Hooren MRA, Vos R, Florie MGMH, Pilz W, Kremer B, Baijens LWJ. Swallowing assessment in Parkinson’s disease: patient
and investigator reported outcome measures are not aligned. Dysphagia 2021;36:864-74. DOI
196. Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 2021;7:47. DOI
PubMed
197. Aarsland D, Kramberger MG. Neuropsychiatric symptoms in Parkinson’s disease. J Parkinsons Dis 2015;5:659-67. DOI PubMed
198. Chen JJ, Marsh L. Anxiety in Parkinson’s disease: identification and management. Ther Adv Neurol Disord 2014;7:52-9. DOI
PubMed PMC
199. Fang C, Lv L, Mao S, Dong H, Liu B. Cognition deficits in Parkinson’s disease: mechanisms and treatment. Parkinsons Dis
2020;2020:2076942. DOI PubMed PMC
200. Weintraub D, Simuni T, Caspell-Garcia C, et al; Parkinson’s Progression Markers Initiative. Cognitive performance and
neuropsychiatric symptoms in early, untreated Parkinson’s disease. Mov Disord 2015;30:919-27. DOI PubMed PMC
201. Polissidis A, Koronaiou M, Kollia V, et al. Psychosis-like behavior and hyperdopaminergic dysregulation in human α-synuclein BAC
transgenic rats. Mov Disord 2021;36:716-28. DOI PubMed
202. Forrest AD, Coto CA, Siegel SJ. Animal models of psychosis: current state and future directions. Curr Behav Neurosci Rep
2014;1:100-16. DOI PubMed PMC
203. Gillies GE, Pienaar IS, Vohra S, Qamhawi Z. Sex differences in Parkinson’s disease. Front Neuroendocrinol 2014;35:370-84. DOI
PubMed PMC
204. Grospe GM, Baker PM, Ragozzino ME. Cognitive flexibility deficits following 6-OHDA lesions of the rat dorsomedial striatum.
Neuroscience 2018;374:80-90. DOI PubMed
205. Marshall CA, King KM, Kortagere S. Limitations of the rat medial forebrain lesion model to study prefrontal cortex mediated
cognitive tasks in Parkinson’s disease. Brain Res 2019;1702:105-13. DOI PubMed
206. Ferris CF, Morrison TR, Iriah S, et al. Evidence of neurobiological changes in the presymptomatic PINK1 knockout rat. J Parkinsons
Dis 2018;8:281-301. DOI PubMed
207. Pham TT, Giesert F, Röthig A, et al. DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit